1.
Galli M, Chatterjee M, Grasso M, Specchia G, Magen H, Einsele H, Celeghini I, Barbieri P, Paoletti D, Pace S, Sanderson RD, Rambaldi A, Nagler A. Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy. Haematologica [Internet]. 2018Sep.30 [cited 2026Nov.16];103(10):e469-e472. Available from: https://haematologica.org/article/view/8641